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Peroxisome proliferator-activated receptor gamma (PPARγ) is a key regulator of
glucose and lipid metabolism and therefore an important pharmacological target to
combat metabolic diseases. Since the currently used full PPARγ agonists display
serious side effects, identification of novel ligands, particularly partial agonists, is
highly relevant. Searching for new active compounds, we investigated extracts of the
underground parts of Notopterygium incisum, a medicinal plant used in traditional
Chinese medicine, and observed significant PPARγ activation using a PPARγ-driven
luciferase reporter model. Activity-guided fractionation of the dichloromethane
extract led to the isolation of six polyacetylenes, which displayed properties of
selective partial PPARγ agonists in the luciferase reporter model. Since PPARγ
activation by this class of compounds has so far not been reported, we have chosen
the prototypical polyacetylene falcarindiol for further investigation. The effect of
falcarindiol (10 µM) in the luciferase reporter model was blocked upon co-treatment
with the PPARγ antagonist T0070907 (1 µM). Falcarindiol bound to the purified
human PPARγ receptor with a Ki of 3.07 µM. In silico docking studies suggested a
binding mode within the ligand binding site, where hydrogen bonds to Cys285 and
Glu295 are predicted to be formed in addition to extensive hydrophobic interactions.
Furthermore, falcarindiol further induced 3T3-L1 preadipocyte differentiation and
enhanced the insulin-induced glucose uptake in differentiated 3T3-L1 adipocytes
confirming effectiveness in cell models with endogenous PPARγ expression. In
conclusion, we identified falcarindiol-type polyacetylenes as a novel class of natural
partial PPARγ agonists, having potential to be further explored as pharmaceutical
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